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Fig. S1 (Azami S. et.al.)
Fig. S1: Schematic representation of pGL3ti-250 reporter containing the ELK-1 
binding sites. Three ELK-1 –binding sites possesses consensus sequence GG(A)T at 
position +1066, +1077, and +1156 within the first intron of the TMEPAI gene. The 
binding site mutants were made by changing GGAT to TGCT. 
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Fig. S2 (Azami S. et.al.)
Fig. S2: EGF/Ras/MAPK pathway enhances TGF-β induced-TMEPAI expression. HaCaT-
RasG12V cells were treated with MEK inhibitor U0126, as indicated, 1 h before TGF-β (0.5
ng/ml) stimulation for 8 h. Cell lysates were subjected to immunoblot analysis and detected
with anti-TMEPAI antibody (9F10). The levels of phosphorylated Erk, total ERK,
phosphorylated Smad2, Smad2 and HA-RasG12V were also detected to examine the effects of
TGF-β and U0126 treatments. β-actin was used as the loading control. Relative expression
levels of TMEPAI/β-actin were detected by densitometry and indicated below the panels.
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Fig. S3 (Azami S. et.al.)
Fig. S3: Transcriptional activity of TMEPAI promoter upon EGF and TGF-β stimulation.
(A) Schematic representation of the TMEPAI 5’-promoter luciferase reporter construct -
1972TMEPAI-luc. The nucleotide numbers of mouse TMEPAI gene was shown with the
transcriptional initiation site as +1. (B) HepG2 cells were transfected with -1972TMEPAI-luc
and stimulated with EGF (10 ng/ml), TGF-β (0.1 ng/ml), or both EGF (10 ng/ml) and TGF-β
(0.1 ng/ml) for 18 h.
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Fig. S4 (Azami S. et.al.)
Fig. S4: The effect of EGF on Smad dependent transcription. HepG2 were transfected 
with (CAGA)12-Luc and treated with EGF for 18 h with indicated concentrations in the 
presence or absence of TGF-β (0.1 ng/ml) stimulation. 
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Fig. S5: The involvement of  AP-1 transcriptional factor on TMEPAI expression.
HepG2 cells were transfected with pGL3ti-850 together with c-Fos and/or c-Jun  as 
indicated in the presence or absence of TGF-β (0.1ng/ml) for 18h. 
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Fig. S6 (Azami S. et.al.)
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Fig. S6: Transcriptional activity of the first intron of TMEPAI gene upon EGF 
and TGF-β stimulation. HepG2 cells were transfected with pGL3ti-850-luc or 
pGL3ti-250-luc, and stimulated with EGF (10 ng/ml), TGF-β (0.1 ng/ml), or both EGF 
(10 ng/ml) and TGF-β (0.1 ng/ml) for 18 h. (*P < 0.05) 
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